<div id="readability-page-1"><div><p>Embecta (EMBC) opened 2026 with Q1 revenue of US$261.2 million and basic EPS of US$0.75, alongside trailing twelve month revenue of about US$1.1 billion and EPS of US$2.38. These figures sit against trailing earnings growth of 139.7% and revenue growth of 0.8% year over year. Over recent quarters the company has seen revenue move between US$259 million and US$295.5 million, while quarterly basic EPS has ranged from US$0.25 to US$0.78. Together this sets up a picture of improving net profit margins from 5.3% to 12.9%, putting profitability at the center of this earnings story.</p> <p>See our full analysis for Embecta.</p><p>With the latest results on the table, the next step is to see how these margin trends line up with the widely followed bullish and bearish narratives around Embecta and where those stories might be challenged by the numbers.</p> <p>See what the community is saying about Embecta</p> <figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fc1e64ad-05b1-4cf9-8f5a-80a1c0e29ff2/chart/earnings-and-revenue-history/query-ZGF0ZT0yMDI2LTA1LTA2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fc1e64ad-05b1-4cf9-8f5a-80a1c0e29ff2/chart/earnings-and-revenue-history/query-ZGF0ZT0yMDI2LTA1LTA2"/><figcaption>NasdaqGS:EMBC Earnings &amp; Revenue History as at May 2026</figcaption></figure> <h2>TTM earnings up 139.7% while revenue stays flat</h2> <ul> <li>Over the last twelve months, net income reached US$139.5 million on US$1.08b of revenue, with earnings up 139.7% year over year while revenue growth is described at 0.8% annually.</li> <li>What stands out for the bullish view is that this sharp earnings rise comes alongside expectations for only about 0.3% annual earnings growth and 0.8% revenue growth, which     <ul> <li>supports the idea that recent cost actions and efficiency gains are doing a lot of the work rather than rapid sales expansion,</li> <li>but also means bulls need to consider how a flat top line could affect any thesis that leans on longer term growth in earnings per share.</li> </ul> </li> </ul><p> Consistent profit at this size with only modest revenue growth is exactly the sort of backdrop bullish investors point to when they argue Embecta can do more with what it already has. That is the story unpacked in detail in the <strong>🐂 Embecta Bull Case</strong>. </p><h2>Margins at 12.9% versus 5.3% a year ago</h2> <ul> <li>Net profit margin is reported at 12.9% for the trailing year compared with 5.3% the year before, while quarterly net income moved between US$14.6 million and US$45.5 million across recent periods on roughly US$259 million to US$295.5 million of revenue per quarter.</li> <li>Bears highlight that a lot of the margin uplift may reflect one off or hard to repeat items, and the data points such as guidance for relatively flat revenue and earnings forecasts of about 0.3% growth     <ul> <li>fit with a cautious view that sustaining a 12.9% margin could be challenging if cost savings or non recurring benefits slow,</li> <li>and sit alongside risks like negative shareholders’ equity and debt not well covered by operating cash flow that keep the focus firmly on the quality and durability of those margins.</li> </ul> </li> </ul><p> Skeptical investors often zoom in on this kind of margin step up and ask how much is repeatable. That is exactly the sort of question unpacked further in the <strong>🐻 Embecta Bear Case</strong>. </p><h2>P/E of 1.7x and price 84% below DCF fair value</h2> <ul> <li>At a share price of US$3.90, Embecta is described as trading on a P/E of 1.7x versus industry and peer averages around 23x, and well below a stated DCF fair value of US$24.48, which implies the stock price is roughly 84.1% under that DCF figure.</li> <li>Consensus narrative points out that this gap exists alongside negative shareholders’ equity, limited debt cover from operating cash flow, and relatively low forecast growth     <ul> <li>which gives investors a mix of potential reward in the valuation discount and one year earnings rebound,</li> <li>against materially flagged risks on the balance sheet and more muted growth expectations than the broader US market.</li> </ul> </li> </ul> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Embecta on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.</p> <p>With sentiment clearly split between opportunity and risk, it makes sense to look through the data yourself and decide how you feel about the stock. To help you weigh both sides, take a moment to review the 3 key rewards and 3 important warning signs.</p> <h2>Explore Alternatives</h2> <p>Embecta pairs flat revenue with rising margins and a very low P/E, but its negative shareholders’ equity and debt coverage concerns keep risk firmly in focus.</p> <p>If that balance sheet risk feels uncomfortable, you can compare this profile against companies screened for stronger financial footing by checking the solid balance sheet and fundamentals stocks screener (46 results)</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data     and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your     financial situation. We aim to bring you long-term focused analysis driven by fundamental data.     Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.     Simply Wall St has no position in any stocks mentioned.</em></p><div><h3>Valuation is complex, but we're here to simplify it.</h3><p>Discover if Embecta might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><p>Access Free Analysis</p></div></div></div>

EMBC

<p>Embecta (EMBC) reported Q1 2026 revenue of $261.2 million and EPS of $0.75, with a trailing twelve-month revenue of $1.1 billion and EPS of $2.38. The company achieved a net profit margin of 12.9%, up from 5.3% the previous year, despite flat revenue growth of 0.8%. While bullish investors highlight the margin improvement, bears caution that sustaining this margin may be challenging due to potential one-off benefits and negative shareholders' equity. Embecta's stock trades at a P/E of 1.7x, significantly below its DCF fair value of $24.48, indicating a potential investment opportunity amid risks.</p>

Embecta (EMBC) Margin Expansion To 12.9% Tests Bearish Earnings Sustainability Narrative